Health and Healthcare
J&J Manages to Beat Earnings Despite Currency Drag
Published:
Last Updated:
Johnson & Johnson (NYSE: JNJ) has now reported its first-quarter results, showing an 8.5% gain in sales to $17.5 billion, and earnings of $4.1 billion on a normalized earnings basis that came to $1.44 in earnings per share. Thomson Reuters was calling for $1.40 per share earnings and $17.44 billion in sales. Domestic sales increased 11.2%, while international sales rose by 6.3% after a negative currency impact of 2.4%.
J&J also has gone out and reconfirmed its earnings guidance for fiscal 2013 in a range of $5.35 to $5.45 per share, but it noted that guidance excludes the impact of special items. Thomson Reuters had estimates of $5.40 per share.
Worldwide consumer sales rose by 2.2% to $3.7 billion for the first quarter, after a negative impact from currency of 1.1%. Worldwide pharmaceutical sales were up 10.4% to $6.8 billion for the first quarter, after a negative impact from currency of 1.0%.
We did not see information regarding the dividend, but we have been expecting a dividend hike. Shares closed at $81.71 yesterday, against a 52-week range of $61.71 to $83.09.
Credit card companies are at war, handing out free rewards and benefits to win the best customers. A good cash back card can be worth thousands of dollars a year in free money, not to mention other perks like travel, insurance, and access to fancy lounges. See our top picks for the best credit cards today. You won’t want to miss some of these offers.
Flywheel Publishing has partnered with CardRatings for our coverage of credit card products. Flywheel Publishing and CardRatings may receive a commission from card issuers.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.